miR-214靶向GSK-3β以促进胃癌细胞增殖并减少细胞凋亡。
Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
作者信息
Li H-L, Liang S, Cui J-H, Han G-Y
机构信息
The 2nd Department of General Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, China.
出版信息
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7574. doi: 10.26355/eurrev_202007_22245.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis, by H.-L. Li, S. Liang, J.-H. Cui, G.-Y. Han, published in Eur Rev Med Pharmacol Sci 2018; 22 (1): 127-134-DOI: 10.26355/eurrev_201801_14109-PMID: 29364479" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14109.
由于本文被怀疑存在研究不当行为，且通讯作者未回应我们关于证明数据和图表原创性的要求，H.-L. Li、S. Liang、J.-H. Cui、G.-Y. Han发表于《欧洲医学与药理学评论》2018年；22(1):127 - 134 - DOI: 10.26355/eurrev_201801_14109 - PMID: 29364479的文章“miR - 214靶向GSK - 3β促进胃癌细胞增殖并减少细胞凋亡”已被撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/14109
Zotero 插件